Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report

Autor: Mirshahidi, Hamid, Kwon, Sue Min Sophia, Romagnolo, Alberto, Park, Kiwon, Hagele, Adam
Zdroj: In Current Problems in Cancer: Case Reports September 2023 11
Databáze: ScienceDirect